The Lamp2b-MSTP vector was transfected into satellite cells using Effectene (Qiagen, Valencia, CA, USA). After 6 hours of transfection, the cells were transduced with Ad-miR-26a (adenovirus containing miR-26a) or Ad-empty (control virus) in the medium containing 2% extracellular vesicle free serum (EVFS). Fresh EVFS medium was changed after 24 hours. The cells were cultured for an additional 48 hours to allow exosome release into the medium. The exosomes that are enriched with miR-26a (Exo/miR-26a) or control (Exo/ctrl) were harvested from culture medium. The proteins from cultured satellite cells and exosome isolated from conditional medium were used to detect exosome maker protein, TSG101. The Western blot showed TSG101 abundance from cells, exosome isolated from the conditional medium with control adenovirus (Exo/ctrl) and with Ad-miR-26a (Exo/miR-26a). First, we created a vector which produces Lamp2b (lysosomal-associated membrane protein 2b) fused with the muscle specific surface peptide (SKTFNTHPQSTP) 3 (#1 in Figure S4 ). An exosome with this peptide will target to skeletal and heart. Second, we co-transfected this vector, along with miR-26a, into donor cells (#2 in Figure S4 ).
The exosomes produced from these cells contain miR-26a and will tend to go to muscle. Third, we collected the targeting exosomes with their miR cargo that were secreted into the conditioned medium by the donor cells (#3 in Figure S4 ). Fourth, we injected the exosome/miR into skeletal muscle of CKD mice (#4 in Figure S4 ).
Fifth, muscle releases Exo/miR into the circulation (#5 in Figure S4 ). Because
Lamp2b is ubiquitously expressed on the surface of exosomes, it can bring the targeting peptides (SKTFNTHPQSTP) 3 to the exosomes surface and endow exosome-encapsulated miR-26a with targeting ability (#6 in Figure S4 ). nephrectomy. At the first week we removed 2/3 of the left kidney, after one week recovery, we removed the right side kidney. After 2nd surgery, CKD mice were fed 14% protein rodent maintenance diet chow (Harlan Teklad, Madison, WI, USA) ad libitum for 7 days before sham-operated mice were weight-matched with a CKD mouse and pair-fed a 14% protein diet for 2 weeks and 40% protein diet for 5 weeks.
We started Exo/miR-26a or Exo/control tibialis anterior (TA) injection after second CKD surgery, 40 ug exosomes each time, once per week total 8 weeks. All mice were feed with 0.9% salts water from the 2nd week. CKD mice with blood urea nitrogen (BUN) ~100 mg/dl (Roche Diagnostics Corpo-ration, IN, USA) were studied.
Generation of exosome encapsulated miR-26a:
We created a vector which produces Lamp2b (lysosomal-associated membrane protein 2b) fused with the Muscle specific surface peptide (KKEEE)3K (#1 in Figure 1 ). Satellite cells were grown to 60% confluence in DMEM/F12 culture medium containing 20% fetal bovine serum.
The Lamp2b-MSTP vector was transfected into satellite cells (#2 in Figure 1 ) using the Effectene transfection reagent (Qiagen, Valencia, CA, USA). Six hours after transfection, the cells were transduced with Ad-miR-26a (adenovirus containing miR-26a processor sequences) to produce exosome encapsulated miR-26a
(Exo/miR-26a) [1] . Control cells were transduced with Ad-empty for production of MSTP-exosome-control (Exo/ctrl). Exosome-free medium was used to replace the growth medium to allow exosome secretion for 48 hours. Last, the pLamp2b/MSTP-miR-26a enriched exosomes (Exo/miR-26a) and pLamp2b/MSTP-ctrl exosomes (Exo/ctrl) were isolated from the conditioned medium of cultured cells and re-suspended in PBS (#3 in Figure 1 ).
Exosome purification, analysis, and modifying: Exosomes were purified by several centrifugation and filtration steps as described previously [2] . Briefly, the supernatant was centrifuged at 2,000 g for 10 minutes, and 16,000 g for 30 minutes, followed by filtration through a 0.22-µm filter to eliminate cells and cellular debris.
The supernatant was ultra-centrifuged at 160,000 g for 180 minutes (Ultracentrifuge, Beckman Coulter, L8-70M). The exosomes pellets were re-suspended in PBS and stored at -80˚C. Exosomes were analyzed by NanoSight instrument measurement ( Figure S2 ) and the presence of the exosomal marker protein TSG101 by western blot ( Figure S3 ). we injected the exosome/miR into skeletal muscle of CKD mice (#4 in Figure 1 ). Muscle releases Exo/miR into the circulation (#5 in Figure 1 ). Because
Lamp2b is ubiquitously expressed on the surface of exosomes, it can bring the targeting peptides (e.g. (KKEEE)3K) to the exosomes surface and endow exosome-encapsulated cargo (e.g. miR-26) with targeting ability (#6 in Figure 1 ).
Real time Quantitative PCR (qPCR):
To measure microRNA, total RNA was extracted using Tri-Reagent (Molecular Research Inc., Cincinnati, OH). For synthesis cDNA, 10ng of total RNA that was enriched in small RNAs was reverse transcripted using the NCode miRNA cDNA synthesis kit (Exiqon, Vedbaek, Denmark). The expression of pri-miR and pre-miR was measured as described [3] . PCR was used the USA) [7] . We calculated the results as the ratio of firefly luciferase to renilla
luciferase (×100). Results from control experiments (e.g, pLuc-3UTR-FOXO1
expressing cells that were treated with a control adenovirus) are expressed as 100%.
Experimental results were calculated in the same fashion and expressed as a percent of control levels. Virus Reagents: The Ad-miR-26a and control virus (Ad-empty) were produced by Emory Integrated Genomics Core. The adenovirus transduction unit (TU) was achieved by serial dilutions, and 5µl of the concentrated viral preparation (109 TU) was added to 2ml media and applied to 6well plates; 90% of cells were transduced (based on green fluorescent protein expression). We used the Ad-miR-26a adenovirus to express miR-26a. Adenovirus transduction was accomplished when growth media was changed to differentiation media.
Echocardiographic Evaluations of Cardiac Function: Echocardiography was
performed on lightly anesthetized mice (under 1-2% isoflurane, in oxygen) using a Vevo 3,100 ultrasound system (VisualSonics, Toronto, CA) as described previously [8] . Statistical analysis: Data were presented as mean ± se. To identify significant differences between two groups, comparisons were made by using the t-test.
Differences with P values < 0.05 were considered significant. For a comparison of more than two groups, one-way ANOVA was performed with a post hoc analysis by the StudentNewman-Keuls test. Differences with P values < 0.05 were considered significant.
